Design, synthesis, and pharmacological evaluation of 2-amino-5-nitrothiazole derived semicarbazones as dual inhibitors of monoamine oxidase and cholinesterase: effect of the size of aryl binding site

References

• Perrin RJ, Fagan AM, Holtzman DM. Multimodal techniques for diagnosis and prognosis of Alzheimer's disease. Nature 2009;461:916–22.
   PubMed Web of Science ®Google Scholar
• Querfurth HW, LaFerla FM. Alzheimer's disease. N Engl J Med 2010;362:329–44.
   PubMed Web of Science ®Google Scholar
• Siddiqui A, Hanson I, Andersen JK. MAO-B elevation decreases parkin’s ability to efficiently clear damaged mitochondria: protective effects of rapamycin. Free Radic Res 2012;46:1011–8.
   PubMed Web of Science ®Google Scholar
• Weinstock M. Selectivity of cholinesterase inhibition: clinical implications for the treatment of Alzheimer’s disease. CNS Drugs 1999;12:307–23.
   Web of Science ®Google Scholar
• Youdim MBH, Bar-Am OM, Yogev-Falach M, Weinreb O, et al. Rasagiline: neurodegeneration, neuroprotection, and mitochondrial permeability transition. J Neurosci Res 2005;79:172–9.
   PubMed Web of Science ®Google Scholar
• Cavalli A, Bolognesi ML, Minarini A, et al. Multi-target-directed ligands to combat neurodegenerative diseases. J Med Chem 2008;51:347–72.
   PubMed Web of Science ®Google Scholar
• Maria LB, Carlo M, Cornelis JVS, Moussa Y, Discovery of multi-target agents for neurological diseases via ligand design. In: Morphy JR, Harris CJ, eds. Designing multi-target drugs. Cambridge: The Royal Society of Chemistry; 2012:290–315.
   Google Scholar
• Leon R, Garcia AG, Marco-Contelles J. Recent advances in the multitarget-directed ligands approach for the treatment of Alzheimer’s disease. Med Res Rev 2013;33:139–89.
   PubMed Web of Science ®Google Scholar
• Vina D, Matos MJ, Yanez M, et al. 3-Substituted coumarins as dual inhibitors of AChE and MAO for the treatment of Alzheimer’s disease. Med Chem Commun 2012;3:213–8.
   Web of Science ®Google Scholar
• D’Ascenzio M, Chimenti P, Gidaro MC, et al. (Thiazol-2-yl)hydrazone derivatives from acetyl pyridines as dual inhibitors of MAO and AChE: synthesis, biological evaluation and molecular modeling studies. J Enzyme Inhib Med Chem 2015;30:908–19.
   PubMed Web of Science ®Google Scholar
• Fink DM, Palermo MG, Bores GM, et al. Imino 1,2,3,4-tetrahydrocyclopent(b)indolecarbamates as dual inhibitors of acetylcholinesterase and monoamine oxidase. Bioorg Med Chem Lett 1996;6:625–30.
   Web of Science ®Google Scholar
• Bruhlmann C, Ooms F, Carrupt PA, et al. Coumarins derivatives as dual inhibitors of acetylcholinesterase and monoamine oxidase. J Med Chem 2001;44:3195–8.
   PubMed Web of Science ®Google Scholar
• Bolea I, Juarez-Jimenez J, de Los Rios C, et al. Synthesis, biological evaluation, and molecular modeling of donepezil and N-((5-(benzyloxy)-1-methyl-1H-indol-2-yl)methyl)-N-methylprop-2-yn-1-amine hybrids as new multipotent cholinesterase/monoamine oxidase inhibitors for the treatment of Alzheimer’s disease. J Med Chem 2011;54:8251–70.
   PubMed Web of Science ®Google Scholar
• Westlund KN, Denney RM, Kochersperger LM, et al. Distinct monoamine oxidase A and B populations in primate brain. Science 1985;230:181–3.
   PubMed Web of Science ®Google Scholar
• Westlund KN, Denney RM, Rose RM, Abell CW. Localization of distinct monoamine oxidase A and monoamine oxidase B cell populations in human brainstem. Neuroscience 1988;25:439–56.
   PubMed Web of Science ®Google Scholar
• Chaurasiya ND, Ganesan S, Nanayakkara NPD, et al. Inhibition of human monoamine oxidase A and B by 5-phenoxy 8-aminoquinoline analogs. Bioorg Med Chem Lett 2012;22:1701–4.
   PubMed Web of Science ®Google Scholar
• Youdim MBH, Finberg JP. New directions in monoamine oxidase A and B selective inhibitors and substrates. Biochem Pharmacol 1991;41:155–62.
   PubMed Web of Science ®Google Scholar
• Gottowik J, Cesura AM, Malherbe P, et al. Characterisation of wild-type and mutant forms of human monoamine oxidase A and B expressed in a mammalian cell line. FEBS Lett 1993;317:152–6.
   PubMed Web of Science ®Google Scholar
• Geha RM, Rebrin I, Chen K, Shih JC. Substrate and inhibitor specificities for human monoamine oxidase A and B are influenced by a single amino acid. J Biol Chem 2001;276:9877–82.
   PubMed Web of Science ®Google Scholar
• Bach AWJ, Lan NC, Johnson DL, et al. cDNA cloning of human liver monoamine oxidase A and B: molecular basis of differences in enzymatic properties. Proc Nat Acad Sci USA 1988;85:4934–8.
   PubMed Web of Science ®Google Scholar
• Greenawalt JW, Schnaitman C. An appraisal of the use of monoamine oxidase as an enzyme marker for the outer membrane of rat liver mitochondria. J Cell Biol 1970;46:173–9.
   PubMed Web of Science ®Google Scholar
• Grimsby J, Chen K, Wang LJ, et al. Human monoamine oxidase A and B genes exhibit identical exon-intron organization. Proc Natl Acad Sci USA 1991;88:3637–41.
   PubMed Web of Science ®Google Scholar
• Rudorfer MV, Potter WZ. Antidepressants. A comparative review of the clinical pharmacology and therapeutic use of the 'newer' versus the 'older' drugs. Drugs 1989;37:713–38.
   PubMed Web of Science ®Google Scholar
• Palhagen S, Heinonen E, Hagglund J, et al. Selegiline slows the progression of the symptoms of Parkinson disease. Neurology 2006;66:1200–6.
   PubMed Web of Science ®Google Scholar
• Youdim MBH, Fridkin M, Zheng H. Novel bifunctional drugs targeting monoamine oxidase inhibition and iron chelation as an approach to neuroprotection in Parkinson’s disease and other neurodegenerative diseases. J Neural Transm 2004;111:1455–71.
   PubMed Web of Science ®Google Scholar
• Cesura AM, Pletscher A. The new generation of monoamine oxidase inhibitors. Prog Drug Res 1992;38:171–297.
   PubMedGoogle Scholar
• Guay DR. Rasagiline (TVP-1012): A new selective monoamine oxidase inhibitor for Parkinson's disease. Am J Geriatr Pharmacother 2006;4:330–46.
   PubMedGoogle Scholar
• Riederer P, Danielczyk W, Grunblatt E. Monoamine oxidase-B inhibition in Alzheimer's disease. Neurotoxicology 2004;25:271–7.
   PubMed Web of Science ®Google Scholar
• Saura J, Luque JM, Cesura AM, et al. Increased monoamine oxidase B activity in plaque-associated astrocytes of Alzheimer brains revealed by quantitative enzyme radioautography. Neuroscience 1994;62:15–30.
   PubMed Web of Science ®Google Scholar
• Lu C, Guo Y, Yan J, et al. Design, synthesis, and evaluation of multitarget-directed resveratrol derivatives for the treatment of Alzheimer’s disease. J Med Chem 2013;56:5843–59.
   PubMed Web of Science ®Google Scholar
• Kalgutkar AS, Dalvie DK, Castagnoli N, Taylor TJ. Interactions of nitrogen-containing xenobiotics with monoamine oxidase (MAO) isozymes A and B: SAR studies on MAO substrates and inhibitors. Chem Res Toxicol 2001;14:1139–62.
   PubMed Web of Science ®Google Scholar
• Massoulie J, Pezzementi L, Bon S, et al. Molecular and cellular biology of cholinesterases. Prog Neurobiol 1993;41:31–91.
   PubMed Web of Science ®Google Scholar
• Brimijoin S. Molecular forms of acetylcholinesterase in brain, nerve and muscle: nature, localization and dynamics. Prog Neurobiol 1983;21:291–322.
   PubMed Web of Science ®Google Scholar
• Heller M, Hanahan DJ. Human erythrocyte membrane bound enzyme acetylcholinesterase. Biochim Biophys Acta 1972;17:251–72.
   Web of Science ®Google Scholar
• Szelenyi JG, Bartha E, Hollan SR. Acetylcholinesterase activity of lymphocytes: an enzyme characteristic of T-cells. Br J Haematol 1982;50:241–5.
   PubMed Web of Science ®Google Scholar
• Mesulam MM, Guillozet A, Shaw P, et al. Acetylcholinesterase knockouts establish central cholinergic pathways and can use butyrylcholinesterase to hydrolyze acetylcholine. Neuroscience 2002;110:627–39.
   PubMed Web of Science ®Google Scholar
• Grisaru D, Sternfeld M, Eldor A, et al. Structural roles of acetylcholinesterase variants in biology and pathology. Eur J Biochem 1999;264:672–86.
   PubMedGoogle Scholar
• Silver A. The biology of cholinesterases. Amsterdam: Elsevier; 1974.
   Google Scholar
• Li B, Stribley JA, Ticu A, et al. Abundant tissue butyrylcholinesterase and its possible function in the acetylcholinesterase knockout mouse. J Neurochem 2000;75:1320–31.
   PubMed Web of Science ®Google Scholar
• Son SY, Ma J, Kondou Y, et al. Structure of human monoamine oxidase A at 2.2-Å resolution: the control of opening the entry for substrates/inhibitors. Proc Natl Acad Sci USA 2008;105:5739–44.
   PubMed Web of Science ®Google Scholar
• Binda C, Wang J, Pisani L, et al. Structures of human monoamine oxidase B complexes with selective noncovalent inhibitors: safinamide and coumarin analogs. J Med Chem 2007;50:5848–52.
   PubMed Web of Science ®Google Scholar
• Cheung J, Rudolph MJ, Burshteyn F, et al. Structures of human acetylcholinesterase in complex with pharmacologically important ligands. J Med Chem 2012;55:10282–6.
   PubMed Web of Science ®Google Scholar
• Nachon F, Carletti E, Ronco C, et al. Crystal structures of human cholinesterases in complex with huprine W and tacrine: elements of specificity for anti-Alzheimer’s drugs targeting acetyl-and butyryl-cholinesterse. Biochem J 2013;453:393–9.
   PubMed Web of Science ®Google Scholar
• Nicolet Y, Lockridge O, Masson P, et al. Crystal structure of human butyrylcholinesterse and of its complexes with substrate and products. J Biol Chem 2003;278:41141–7.
   PubMed Web of Science ®Google Scholar
• Medvedev AE, Ivanov AS, Veselovsky AV, et al. QSAR analysis of indole analogues as monoamine oxidase inhibitors. J Chem Inf Comput Sci 1996;36:664–71.
   PubMedGoogle Scholar
• Bag S, Tulsan R, Sood A, Datta S. Pharmacophore modeling, virtual and in vitro screening for acetylcholinesterase inhibitors and their effects on amyloid-β self-assembly. Curr Comput Aided Drug Des 2013;9:2–14.
   PubMed Web of Science ®Google Scholar
• Pandeya SN, Raja AS, Stables JP. Synthesis of isatin semicarbazones as novel anticonvulsants – role of hydrogen bonding. J Pharm Pharm Sci 2002;5:266–71.
   PubMed Web of Science ®Google Scholar
• Raja AS, Pandeya SN, Panda SS, Stables JP. Synthesis and anticonvulsant evaluation of semicarbazones of acetophenone Mannich bases. Pharm Chem J 2007;41:302–7.
   Web of Science ®Google Scholar
• Tripathi RKP, Goshain O, Ayyannan SR. Design, synthesis, in vitro MAO-B inhibitory evaluation, and computational studies of some 6-nitrobenzothiazole-derived semicarbazones. ChemMedChem 2013;8:462–74.
   PubMed Web of Science ®Google Scholar
• Tripathi RKP, Rai GK, Ayyannan SR. Exploration of a library of 3,4-(Methylenedioxy)aniline-derived semicarbazones as dual inhibitors of monoamine oxidase and acetylcholinesterase: design, synthesis, and evaluation. ChemMedChem 2016;11:1145–60.
   PubMed Web of Science ®Google Scholar
• Tripathi RKP, Krishnamurthy S, Ayyannan SR. Discovery of 3-hydroxy-3-phenacyloxindole analogues of isatin as potential monoamine oxidase inhibitors. ChemMedChem 2016;11:119–32.
   PubMed Web of Science ®Google Scholar
• Ellman GL, Courtney KD, Andres V, Jr, FeatherStone RM. A new and rapid colorimetric determination of acetylcholinesterase activity. Biochem Pharmacol 1961;7:88–95.
   PubMed Web of Science ®Google Scholar
• MarvinSketch (version 6.2.2). Calculation module developed by ChemAxon; 2014. Available from: http://www.chemaxon.com/products/marvin/marvinsketch/ [last accessed 27 Oct 2014].
   Google Scholar
• Rajesh MP, Natvar JP. In vitro antioxidant activity of coumarin compounds by DPPH, Super oxide and nitric oxide free radical scavenging methods. J Adv Pharm Educ Res 2011;1:52–68.
   Google Scholar
• Krall RI, Penry JK, White BG, et al. Antiepileptic drug development: II. Anticonvulsant drug screening. Epilepsia 1978;19:409–28.
   PubMed Web of Science ®Google Scholar
• Porter RJ, Cereghino JJ, Gladding GD, et al. Antiepileptic drug development program. Cleveland Clin Quart 1984;51:293–305.
   PubMedGoogle Scholar
• Strydom B, Malan SF, Castagnoli N, Jr, et al. Inhibition of monoamine oxidase by 8-benzyloxyfacceine analogues. Bioorg Med Chem 2010;18:1018–28.
   PubMed Web of Science ®Google Scholar
• Goodsell DS, Morris GM, Olson AS. Automated docking of flexible ligands: applications of AutoDock. J Mol Recogn 1996;9:1–5.
   PubMed Web of Science ®Google Scholar
• Chimenti F, Bolasco A, Secci D, et al. Investigations on the 2-Thiazolyl hydrazyne scaffold: synthesis and molecular modeling of selective human monoamine oxidase inhibitors. Bioorg Med Chem 2010;18:5715–23.
   PubMed Web of Science ®Google Scholar
• Benchekroun M, Bartolini M, Egea J, et al. Novel tacrine-grafted Ugi adducts as multipotent anti-alzheimer drugs: a synthetic renewal in tacrine-ferulic acid hybrids. ChemMedChem 2015;10:523–39.
   PubMed Web of Science ®Google Scholar